Episode Details

Back to Episodes
Episode 136: ESMO 2021: STAMPEDE Abiraterone for high-risk non-metastatic prostate cancer

Episode 136: ESMO 2021: STAMPEDE Abiraterone for high-risk non-metastatic prostate cancer

Season 1 Episode 136 Published 5 years, 1 month ago
Description

Gert Attard describes this practice-changing plenary data. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us